Instituto de Quimica, Universidade de Brasilia, 70910-970 Brasilia, DF, Brazil.
J Med Chem. 2010 Jan 14;53(1):504-8. doi: 10.1021/jm900865m.
Several 3-arylamino and 3-alkoxy-nor-beta-lapachone derivatives were synthesized in moderate to high yields and found to be highly potent against cancer cells SF295 (central nervous system), HCT8 (colon), MDA-MB435 (melanoma), and HL60 (leukemia), with IC(50) below 2 microM. The arylamino para-nitro and the 2,4-dimethoxy substituted naphthoquinones showed the best cytoxicity profile, while the ortho-nitro and the 2,4-dimethoxy substituted ones were more selective than doxorubicin and similar to the precursor lapachones, thus emerging as promising new lead compounds in anticancer drug development.
几种 3-芳基氨基和 3-烷氧基-去甲-β-拉帕酮衍生物以中等至高产率合成,并发现对 SF295(中枢神经系统)、HCT8(结肠)、MDA-MB435(黑色素瘤)和 HL60(白血病)的癌细胞具有高度的抑制作用,IC50低于 2μM。芳氨基对硝基和 2,4-二甲氧基取代的萘醌表现出最佳的细胞毒性谱,而邻硝基和 2,4-二甲氧基取代的萘醌比阿霉素更具选择性,与前体拉帕酮相似,因此成为癌症药物开发中很有前途的新先导化合物。